Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Establishing a Diagnostic and Therapeutic Index in Autism Spectrum Disorder (ASD) and Fragile X Syndrome

NCT04869930 is registered in ClinicalTrials.gov with Nova Mentis Life Science Corp as lead sponsor.

NCT NCT04869930
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04869930 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Establishing a Diagnostic and Therapeutic Index in Autism Spectrum Disorder (ASD) and Fragile X Syndrome
Lead sponsor
Nova Mentis Life Science Corp
Phase
Observational
Overall status
Unknown status
Start date
November 1, 2021
Completion date
May 31, 2023
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autism spectrum disorder, fra(x) syndrome